---
title: ClinAgent: A ReAct-Based Agent for Conversational Access to Clinical Trial Information
url: http://arxiv.org/abs/2609.13860v1
type: paper-summary
date: 2026-09-15
source_paper: 2026-09-12_10-25-35Z_ClinAgent_AReAct_BasedAgentforConversationalAccess.md
generated_at: 2026-09-15 13:06
model: timtimtimtimtim/qwen3.6-35b-a3b
---

## Summary
ClinAgent introduces a conversational, agentic Retrie-Augmented Generation system designed to streamline the manual and error-prone process of querying clinical trial registries. By leveraging a Large Language Model agent that follows the ReAct paradigm, the system enables researchers to interact with complex biomedical data through natural language across multi-turn conversations. Evaluation across multiple LLM backends demonstrates that agentic AI can significantly enhance both the accessibility and synthesis of clinical trial information for scientific workflows.

## Key Takeaways
- ClinAgent utilizes a ReAct-based LLM agent integrated with specialized tools, including a ClinicalTrials.gov search interface, a PubMed module, and a Python-based analyzer operating on cached structured datasets to enable grounded, multi-turn natural language querying of clinical trial data.
- The system was rigorously evaluated using a three-phase framework assessing operational effectiveness, planning quality, tool-use efficiency, and expert qualitative judgments across Gemini 3.0 Flash and DeepSeek V3.2 variants.
- Results reveal complementary model strengths: DeepSeek in thinking mode demonstrates superior planning quality, while Gemini achieves the highest overall performance and strongest expert ratings, highlighting the value of agentic AI for biomedical research workflows.

## Context
The rapid expansion of clinical trial registries has created a significant bottleneck for researchers who must manually navigate large volumes of semi-structured data to synthesize evidence. Traditional query methods lack natural language support and cross-source synthesis capabilities, limiting efficiency in evidence-based medicine. This paper addresses a critical gap by applying advanced agentic AI architectures to automate and contextualize clinical trial discovery, aligning with the broader shift toward interactive, reasoning-driven LLM applications in healthcare informatics.

## Implications
By enabling clinicians and researchers to retrieve and synthesize complex trial data through conversational interfaces, ClinAgent reduces manual search overhead and minimizes human error in evidence gathering. The comparative evaluation of different LLM backends provides actionable insights for selecting optimal models based on specific workflow requirements like planning depth versus overall responsiveness. Ultimately, this approach paves the way for more efficient, user-centered biomedical research pipelines and could accelerate translational studies by lowering technical barriers to clinical trial data access.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2609.13860v1)
